• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chlamydia pneumoniae and other risk factors for atherosclerosis.

作者信息

Leinonen M

机构信息

National Public Health Institute, Department in Oulu, FIN-90101 Oulu, Finland.

出版信息

J Infect Dis. 2000 Jun;181 Suppl 3:S414-6. doi: 10.1086/315624.

DOI:10.1086/315624
PMID:10839726
Abstract

Seroepidemiologic studies have provided information on the association of Chlamydia pneumoniae with the classical risk factors of coronary heart disease (CHD). C. pneumoniae infections are more common in smokers than in nonsmokers, suggesting that smoking predisposes to the development of chronic infection. Infections may also affect lipid metabolism. In persons with acute pneumonia caused by C. pneumoniae, high-density lipoprotein (HDL) values are lower and triglyceride values higher than seen in pneumonia caused by viruses and other bacteria. Furthermore, chronic C. pneumoniae infection is associated with elevated triglyceride and lowered HDL levels in healthy Finnish men. Recent studies also suggest that chronic C. pneumoniae infection considerably enhances the effect of the metabolic syndrome on the CHD risk. Thus, known CHD risk factors may be partly explained by their association with chronic C. pneumoniae infection. Further studies are needed to elucidate the pathogenetic mechanisms underlying these associations.

摘要

相似文献

1
Chlamydia pneumoniae and other risk factors for atherosclerosis.
J Infect Dis. 2000 Jun;181 Suppl 3:S414-6. doi: 10.1086/315624.
2
Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis.
Am Heart J. 1999 Nov;138(5 Pt 2):S504-6. doi: 10.1016/s0002-8703(99)70286-3.
3
[Chlamydia pneumoniae pneumonia].[肺炎衣原体肺炎]
Rev Med Univ Navarra. 1998 Jan-Mar;42(1):14-7.
4
Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more.肺炎衣原体与动脉粥样硬化的流行病学关联:初步血清学观察及更多研究
J Infect Dis. 2000 Jun;181 Suppl 3:S411-3. doi: 10.1086/315625.
5
[Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?].[动脉粥样硬化与炎症——肺炎衣原体感染的作用 我们目前了解到什么?]
Wiad Lek. 2004;57(3-4):151-5.
6
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.肺炎衣原体与动脉粥样硬化的背景及当前认知
J Infect Dis. 2000 Jun;181 Suppl 3:S402-10. doi: 10.1086/315596.
7
Chlamydia pneumoniae seropositivity and risk of developing coronary heart disease in Western Saudi Arabia.沙特阿拉伯西部肺炎衣原体血清阳性与冠心病发病风险
Saudi Med J. 2005 Dec;26(12):1926-9.
8
Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.肺炎衣原体感染、炎症标志物与冠心病之间的关系。
Int Immunopharmacol. 2006 May;6(5):848-53. doi: 10.1016/j.intimp.2005.10.012. Epub 2005 Nov 28.
9
Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology.人群中肺炎衣原体与动脉粥样硬化风险:血清流行病学的作用
J Infect Dis. 2000 Jun;181 Suppl 3:S417-20. doi: 10.1086/315623.
10
Chronic infections and coronary heart disease.慢性感染与冠心病
Int J Clin Pract. 1999 Sep;53(6):460-6.

引用本文的文献

1
A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapy.肺炎衣原体中 MOMP 的新型转运机制及其在免疫治疗中的潜在作用。
PLoS One. 2013 Apr 24;8(4):e61139. doi: 10.1371/journal.pone.0061139. Print 2013.
2
Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease.冠心病患者肺炎衣原体感染与HLA - B*35的关联。
Clin Vaccine Immunol. 2008 Jan;15(1):55-9. doi: 10.1128/CVI.00163-07. Epub 2007 Nov 7.
3
Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.
患有和未患动脉粥样硬化患者体内肺炎衣原体的存在情况。
Eur J Clin Microbiol Infect Dis. 2005 Aug;24(8):507-13. doi: 10.1007/s10096-005-1380-0.